Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Zhaoke Ophthalmology's IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE 2021-09-29 12:17
MetaCell launches innovative Cloud Hosting for life science and healthcare 2021-09-29 07:54
EW Nutrition launches Pretect D to support poultry gut health during challenging periods 2021-09-29 07:40
I-Mab Announces Acceptance of IND Application from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors 2021-09-28 20:00
Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy 2021-09-28 08:00
Bo'ao Winhealth Rare Disease Medical Center and Ali Health Jointly Launched the "Global Drug Information Platform for Rare Diseases" 2021-09-27 21:00
Immunoforge Inc. receives U.S. FDA ODD for Treatment of Polymyositis 2021-09-27 21:00
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference 2021-09-27 19:20
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC 2021-09-27 19:02
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis 2021-09-27 17:37
Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting 2021-09-27 08:00
Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients 2021-09-26 23:09
Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit 2021-09-26 10:12
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 14:09
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206 2021-09-24 13:56
Broncus Lists on Main Board of HKEx 2021-09-24 11:52
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 09:18
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases 2021-09-24 08:47
Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis 2021-09-24 08:00
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine 2021-09-23 21:59
1 220 221 222 223 224 413